A new vision for the profession deserves a new edition of The Art and Science!

Learn how to incorporate CGM in your practice to improve outcomes for the populations you serve

Discover the benefits of connected insulin delivery devices, like smart insulin pens, and the integrated data that they provide.

Insights on how to skillfully deliver virtual care

Sponsored by Abbott, learn about the #1 CGM used worldwide*, the FreeStyle Libre 2 system

Sponsored by Abbott, join us to learn about the #1 CGM used worldwide*, the FreeStyle Libre 2 system

Gain a deeper understanding of the Dexcom G6 Real-Time Continuous Glucose Monitoring (RT-CGM) System and the power of data analysis with Dexcom Clarity software by implementing the ICC framework to simplify clinician workflow and improve diabetes management. Sponsored by Dexcom.

Learn about the latest advances with the FreeStyle Libre 2 CGM system. This device training will empower you to efficiently educate on the device and utilize LibreView reports, as well as the FreeStyle Libre apps, to improve diabetes care. Sponsored by Abbott.

This presentation will teach basic concepts of insulin pump therapy and continuous glucose monitoring for those who are new to the field or those who don't work with technology on a regular basis and are looking for a good overview or what is currently available.

This device demonstration will utilize instructional videos and case studies to demonstrate the features and functionality of the Omnipod 5 Automated Insulin Delivery System, highlighting how to support patients and optimize settings.

This session will explore the lessons learned through successful remote monitoring of diabetes-related foot conditions through telemedicine and use of innovative devices in order to avoid lower extremity complications during the COVID-19 pandemic.

There is a tremendous opportunity for diabetes care and education specialists to implement telehealth and remote monitoring to increase access and optimize care for people with diabetes. This session will demonstrate how diabetes care and education specialists can maximize remote care for people with diabetes.

Sponsored by Dexcom.

This presentation will describe an RDN, certified diabetes care and education specialist-led initiative to train and empower direct care RNs to provide diabetes survival skill education using mobile technology.

The MedStar Diabetes Bootcamp serves as a model for expanding the roles and competencies of diabetes care and education specialists. This session will review this approach and how, by increasing access to person-centric care, DSMES and MNT services, this program has demonstrated success in overcoming therapeutic inertia.

This session will describe telehealth programs designed to improve cardiometabolic health with RDNs using approved treatment protocols to initiate/titrate medications for glucose, hypertension and lipids and how data informed their development.

This session will discuss how to navigate telehealth platforms, integrate technology, provide effective outreach, utilize tools for engagement and provide support. Attention to addressing potential barriers and access to care in this new landscape will also be covered.

Sharing diabetes challenges and engaging with peers through Facebook groups helps people with diabetes make connections and learn/reinforce actionable self-care behaviors. This session will discuss how to use social media to teach, reinforce and support people with diabetes.

In this session, speakers will discuss strategies for the diabetes care and education specialist to identify disparities and therapeutic inertia around diabetes technology using the Identify, Configure, Collaborate (ICC) framework.

Advances in technology offer new device choices such as insulin delivery devices, CGM and AID systems. This presentation will provide an update of what diabetes care and education specialists need to know about these new technologies, who will benefit most and what’s in the pipeline.

This presentation will discuss the advantages and challenges of a variety of diabetes mobile health apps and examine creative ways to integrate these tools into clinical practice to help support diabetes self-care management.

Some people with diabetes choose not to use an insulin pump due to factors such as cost, insurance coverage and complexity. This session will review other options for insulin delivery such as smart insulin pens, inhaled insulin and disposable insulin delivery.

This session will present three systematic reviews looking at DSMES interventions as they relate to cost and utilization, technology-enabled self-management, and the impact on quality of life in type 1 diabetes. Recommendations for further research will also be discussed.

Cardiometabolic Syndrome (CMS) is a recognized disease entity in 25% of adults. This session will provide an overview of CMS, the biomarkers that can predict risk and discuss types of technologies, applications and programs to mitigate risk factors.